Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has gradually developed because of rapid hypertrophy of the future liver remnant volume (FLR) in spite of high morbidity. To minimize the patient's postoperative pain and morbidity including wound complication caused by two consecutive major abdominal operations, we adopted a totally laparoscopic approach and used a composite mesh graft. Also, to maximize the oncologic efficacy, we adopted the "anterior approach" technique. A 44-year-old woman with large hepatitis B-related hepatocellular carcinoma (HCC) in her right lobe was transferred to our hospital for surgical treatment. Preoperatively predicted FLR by a CT scan was 21% and type II portal vein anomaly was detected. A totally laparoscopic approach was planned. During the first stage operation, right anterior and posterior portal veins were meticulously dissected and tied. After parenchymal transection by the "anterior approach" technique, two glissonian pedicles of the right liver were individually isolated. A composite mesh graft was used to prevent severe adhesion on both liver partition surfaces. During the second-stage operation, 9 days after the first stage operation, the two isolated glissonian pedicles were initially transected. After full mobilization of the right lobe, the right hepatic vein was also transected. The right lobe was removed through the Pfannenstiel incision. She was discharged 7 days after the second stage operation. Her postoperative course was uneventful and there was no HCC recurrence for 15 months after hepatectomy. A totally laparoscopic ALPPS procedure can be a feasible technique that ensures patient safety and oncologic superiority, even in patients with complicated anatomical variation. 
INTRODUCTION
Small liver remnant volume in hepatocellular carcinoma (HCC)-related liver cirrhosis is associated with significant morbidity and mortality, and it is the main limiting factor for hepatic resection. [1] [2] [3] To increase the resectability and to reduce the incidence of postoperative complications, it is necessary to increase the volume and function of the planned future liver remnant (FLR). 4 The associating liver partition and portal vein ligation (ALPPS)
procedure was introduced as a potential solution to perform extended resection safely by inducing pre-resection liver hypertrophy in patients with multifocal liver cancer or non-resectable liver tumors. 5 But, this technique has a high complication rate and a mortality rate between 12%
and 27% according to the initial reports on ALPPS.
Because ALPPS consists of an extensive first stage procedure that includes hepatic parenchymal transection combined with portal vein ligation, the complication rate may be higher regardless of successful pre-resection liver hypertrophy. Hence, efforts should be made to reduce the morbidity and mortality while maintaining a more rapid FLR hypertrophy. Laparoscopic surgery is known to alleviate the surgical stress and the systemic inflammatory response to all surgeries. 6 Therefore, total or partial use of laparoscopy may help to reduce the surgical difficulties 
Surgical procedures
Laparoscopic ALPPS procedure using the anterior approach was planned to induce rapid hypertrophy of the FLR.
In the first stage, the patient was placed in the left The left portal vein, the left hepatic artery and the middle hepatic vein were well preserved for future liver remnant (Fig. 3) .
The second stage operation (Fig. 4 ) was performed 9 and it was confirmed that the volume increased to 403 ml at 7 days and 604 ml at 2 months after the second stage operation. More stable liver function was obtained after the second stage operation (Fig. 5) .
Postoperative course
Postoperative liver function of this patient steadily improved and complications did not occur. The patient was discharged 7 days after the second stage operation and she had recovered well. On follow-up at postoperative 15 months, imaging studies including a CT scan revealed no tumor in the remnant liver, and AFP and PIVKA II levels were 7.2 ng/ml and 17.07 mAU/ml, respectively, which indicated an absence of tumor recurrence.
DISCUSSION
In patients who require an increase in volume of the planned future liver remnant to enable a potentially curative resection, induction of hypertrophy of the tumor-free lobe prior to resection may mitigate morbidity and mortality. 4 Preoperative portal vein embolization or ligation has been commonly used to achieve hypertrophy of remnant liver volume. But, these techniques are associated with some problems, including delay (between 3 and 8 weeks) 10, 11 or the absence of hypertrophy and the risk of tumor progression between the two stages. The delay or absence of sufficient hypertrophy may be related to the formation of intrahepatic vascular collaterals. Hence, a few reports have suggested that simultaneous occlusion of the intrahepatic collateral circulation and portal vein allows a rapid FLR growth of 40% to 160% in only 6 to 9 days. 4, [12] [13] [14] [15] We were also able to complete this hepatectomy with a much shorter interval of 9 days between the first and second stage operations.
ALPPS can achieve rapid FLR hypertrophy. However, the reported mortality in the initial series from Germany was 12% and 15% in a subsequent multi-centric analysis, reaching a rate of even 27% in experienced hepatobiliary centers. 5, 16, 17 ALPPS was supposed to be an "all-touch" technique that would reduce the oncologic treatment efficacy for liver malignancy. 16 But, totally laparoscopic associating liver tourniquet and portal ligation for staged hepatectomy via the anterior approach for cirrhotic HCC 21 and totally laparoscopic ALPPS, conforming to the "No-Touch" principle 22 were reported. We experienced that laparoscopic ALPPS using the anterior approach technique could be a less invasive procedure that provides improved surgical and survival outcomes.
In conclusion, ALPPS has emerged as a new strategy to increase the resectability of hepatic malignancies.
Laparoscopic ALPPS using the anterior approach technique can provide a minimally invasive modification as a "no-touch technique" that has greater oncologic efficacy.
The laparoscopic ALPPS technique seems to be feasible and safe in the hands of surgeons with expertise, even in patients with anatomical variation of the liver.
